By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Onyvax Limited 

P.O. Box 17717
St George's Hospital Medical School
Cranmer Terrace  London  SW17 0WG  United Kingdom
Phone: 44-181-682-9494 Fax: +44-181-682-9495




Company News
Onyvax Limited Identifies a Biomarker Profile That Could be Predictive of Response to Cancer Vaccines 11/11/2008 4:34:43 PM
Onyvax Limited European Phase IIB Clinical Trial Completes Enrolment 3/17/2008 11:59:28 AM
Onyvax Limited Funding Shot for Cell-Based Vaccines 1/14/2008 10:41:45 AM
Onyvax Limited Release: Phase IIb Clinical Trial Of Onyvax-P In Early Stage Prostate Cancer Initiated In United States 9/28/2007 11:29:37 AM
Onyvax Limited Raises £8 Million To Advance Development Of Prostate Cancer Vaccine 5/8/2006 4:55:58 PM
Eden Biodesign And Onyvax Limited Announce Biomanufacturing Contract 4/6/2006 1:54:53 PM
Onyvax Limited Release: University of Michigan Researchers Zero-In On CD55 3/27/2006 2:18:12 PM
Onyvax Limited Release: Onyvax-105 Cancer Vaccine Shows Encouraging Clinical Results In Osteosarcoma Patients After Intensive Chemotherapy10/19/2005 5:13:13 PM
Asterand, Inc. Announces New Cell Lines To Advance Prostate Cancer Research10/19/2005 5:10:01 PM
Onyvax Limited Publishes Results Of Phase II Prostate Cancer Vaccine Showing Significant Steps Towards Delaying Disease Progression10/19/2005 5:09:13 PM